The effect of years of schooling and age on CERAD-MX performance in Mexican preclinical carriers of the APP V717I mutation: Randomized data simulation.

IF 4 Q1 CLINICAL NEUROLOGY
Angélica Zuno-Reyes, Karina Pérez-Rubio, Martín Alonso Flores-González, Ricardo Jauregui Torres, Sofía Dumois-Petersen, Luis E Figuera, John M Ringman, Esmeralda Matute
{"title":"The effect of years of schooling and age on CERAD-MX performance in Mexican preclinical carriers of the <i>APP</i> <sub>V717I</sub> mutation: Randomized data simulation.","authors":"Angélica Zuno-Reyes, Karina Pérez-Rubio, Martín Alonso Flores-González, Ricardo Jauregui Torres, Sofía Dumois-Petersen, Luis E Figuera, John M Ringman, Esmeralda Matute","doi":"10.1002/dad2.12631","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>We aimed to determine the effect of years of schooling (YoS) and age on the Mexican adaptation of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD-MX) scores in preclinical carriers group (PCG) and non-carriers group (NCG) of the <i>APP</i> <sub>V717I</sub> mutation.</p><p><strong>Methods: </strong>We included 39 first-degree Mexican relatives of <i>APP</i> <sub>V717I</sub> carriers (PCG = 15; NCG = 24). We report eight CERAD-MX tasks: Mini-Mental State Examination (MMSE), Word List Learning (WLL), Delayed Recall (WLD) and Recognition (WLR), Constructional Praxis Copy (CPC) and Recall (CPR), Semantic Verbal Fluency (SVF), and Verbal Boston Naming (VBN), comparing both groups' performance and simulating new samples' random vectors by inverse transform sampling.</p><p><strong>Results: </strong>PCG and NCG performed similarly on CERAD-MX. In both groups, YoS and age influence all <i>z</i> scores. A positive age effect resulted for PCG on CPC and SVF; for the NCG on MMSE, SVF, and VBN.</p><p><strong>Discussion: </strong>All tasks are influenced by YoS. Higher YoS/younger age or YoS/older age interactions affected different tasks, suggesting that YoS confounds outcomes.</p><p><strong>Highlights: </strong>Years of schooling (YoS) and age affect the Mexican adaptation of the Consortium to Establish a Registry for Alzheimer's Disease scores of <i>APP</i> <sub>V717I</sub> preclinical carriers.Preclinical carriers underperformed non-carriers on Constructional Praxis Recall.Fewer YoS emerges as a confounding variable when detecting cognitive failures.Younger participants in both groups overperformed the older ones in the Memory tasks.Randomized data simulation increases statistical power when analyzing rare diseases.</p>","PeriodicalId":53226,"journal":{"name":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","volume":"16 3","pages":"e12631"},"PeriodicalIF":4.0000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11336201/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer''s and Dementia: Diagnosis, Assessment and Disease Monitoring","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/dad2.12631","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: We aimed to determine the effect of years of schooling (YoS) and age on the Mexican adaptation of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD-MX) scores in preclinical carriers group (PCG) and non-carriers group (NCG) of the APP V717I mutation.

Methods: We included 39 first-degree Mexican relatives of APP V717I carriers (PCG = 15; NCG = 24). We report eight CERAD-MX tasks: Mini-Mental State Examination (MMSE), Word List Learning (WLL), Delayed Recall (WLD) and Recognition (WLR), Constructional Praxis Copy (CPC) and Recall (CPR), Semantic Verbal Fluency (SVF), and Verbal Boston Naming (VBN), comparing both groups' performance and simulating new samples' random vectors by inverse transform sampling.

Results: PCG and NCG performed similarly on CERAD-MX. In both groups, YoS and age influence all z scores. A positive age effect resulted for PCG on CPC and SVF; for the NCG on MMSE, SVF, and VBN.

Discussion: All tasks are influenced by YoS. Higher YoS/younger age or YoS/older age interactions affected different tasks, suggesting that YoS confounds outcomes.

Highlights: Years of schooling (YoS) and age affect the Mexican adaptation of the Consortium to Establish a Registry for Alzheimer's Disease scores of APP V717I preclinical carriers.Preclinical carriers underperformed non-carriers on Constructional Praxis Recall.Fewer YoS emerges as a confounding variable when detecting cognitive failures.Younger participants in both groups overperformed the older ones in the Memory tasks.Randomized data simulation increases statistical power when analyzing rare diseases.

受教育年限和年龄对墨西哥 APP V717I 突变临床前携带者 CERAD-MX 表现的影响:随机数据模拟
简介:我们的目的是确定在 APP V717I 突变的临床前携带者组(PCG)和非携带者组(NCG)中,受教育年限(YoS)和年龄对建立阿尔茨海默病登记联盟(CERAD-MX)墨西哥适应性评分的影响:我们纳入了 39 名 APP V717I 基因携带者的墨西哥一级亲属(PCG = 15;NCG = 24)。我们报告了八项 CERAD-MX 任务:我们报告了 8 项 CERAD-MX 任务:迷你精神状态检查 (MMSE)、单词表学习 (WLL)、延迟回忆 (WLD) 和识别 (WLR)、构词法临摹 (CPC) 和回忆 (CPR)、语义口头流畅性 (SVF) 和口头波士顿命名 (VBN),比较了两组的表现,并通过反变换采样模拟了新样本的随机向量:PCG 和 NCG 在 CERAD-MX 上的表现相似。在两组中,YoS 和年龄对所有 z 分数都有影响。PCG 在 CPC 和 SVF 上的年龄效应为正;NCG 在 MMSE、SVF 和 VBN 上的年龄效应为正:讨论:所有任务都受到 YoS 的影响。较高的 YoS/ 较小年龄或 YoS/ 较大年龄的交互作用影响了不同的任务,这表明 YoS 会干扰结果:受教育年限(YoS)和年龄会影响 APP V717I 临床前携带者在墨西哥对建立阿尔茨海默病登记协会评分的适应性。临床前携带者在构建性实践回忆中的表现不如非携带者。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.80
自引率
7.50%
发文量
101
审稿时长
8 weeks
期刊介绍: Alzheimer''s & Dementia: Diagnosis, Assessment & Disease Monitoring (DADM) is an open access, peer-reviewed, journal from the Alzheimer''s Association® that will publish new research that reports the discovery, development and validation of instruments, technologies, algorithms, and innovative processes. Papers will cover a range of topics interested in the early and accurate detection of individuals with memory complaints and/or among asymptomatic individuals at elevated risk for various forms of memory disorders. The expectation for published papers will be to translate fundamental knowledge about the neurobiology of the disease into practical reports that describe both the conceptual and methodological aspects of the submitted scientific inquiry. Published topics will explore the development of biomarkers, surrogate markers, and conceptual/methodological challenges. Publication priority will be given to papers that 1) describe putative surrogate markers that accurately track disease progression, 2) biomarkers that fulfill international regulatory requirements, 3) reports from large, well-characterized population-based cohorts that comprise the heterogeneity and diversity of asymptomatic individuals and 4) algorithmic development that considers multi-marker arrays (e.g., integrated-omics, genetics, biofluids, imaging, etc.) and advanced computational analytics and technologies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信